Epidemiology of restless legs syndrome in French adults

François Tison, Anne Crochard, Damien Léger, +3

Neurology

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.

Claudia Trenkwalder, Diego García‐Borreguero, P. Montagna, +6

PubMed

First-Night Effect in Normal Subjects and Psychiatric Inpatients

Michel Toussaint, R. Luthringer, Nicolas Schaltenbrand, +5

SLEEP

Sleep DisordersMental HealthSocial SciencesPsychologyRem Sleep Latency +14

Sleep Stage Scoring Using the Neural Network Model: Comparison Between Visual and Automatic Analysis in Normal Subjects and Patients

Nicolas Schaltenbrand, Régis Lengelle, Michel Toussaint, +6

SLEEP

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

Diego García‐Borreguero, Ronald R. Grunstein, Guruswamy Sridhar, +6

Sleep Medicine

RheumatologyRestless LegsPharmacotherapy52-Week Open-label StudyLong-term Safety +2

Effects of ipsapirone, a 5‐HT_1Aagonist, on sleep/wakefulness cycles: probable post‐synaptic action

M TISSIER, Eric Lainey, Claude‐Michelle Fattaccini, +2

Journal of Sleep Research

Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects

Stephan Chalon, Álvaro Pereira, Eric Lainey, +4

Psychopharmacology

SleepSleep DisorderHealthy SubjectsNeurophysiologyEeg Signal Processing +10

Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat

Corinne Maudhuit, Thierry Jolas, Eric Lainey, +2

Neuropharmacology

Sleep DisordersSleepSleep MedicineSleep-wakefulness CycleSleep Disorder +8

Acute Colitis Associated with Prolonged Administration of Neuroleptics

Dominique Larrey, Eric Lainey, Pierre Blanc, +7

Journal of Clinical Gastroenterology

Diagnostic indicators of restless legs syndrome in primary care consultations: The DESYR study

Anne Crochard, Abdelkader El Hasnaoui, Denis Pouchain, +10

Movement Disorders